Applied Therapeutics Inc
NASDAQ:APLT
Applied Therapeutics Inc
NASDAQ:APLT
Price:
0.103
USD
3%
Market Closed
Market Cap:
$15.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
B
|
Britania PCL
SET:BRI
|
TH |
|
C
|
Central Japan Railway Co
OTC:CJPRY
|
JP |
|
Entergy Corp
NYSE:ETR
|
US |
|
Blue Sky Uranium Corp
XTSX:BSK
|
CA |
|
Longfor Group Holdings Ltd
HKEX:960
|
CN |
|
Zurich Insurance Group AG
OTC:ZFSVF
|
CH |
|
B
|
Bank of Marin Bancorp
NASDAQ:BMRC
|
US |
|
indie Semiconductor Inc
NASDAQ:INDI
|
US |
|
E
|
Ecolab Inc
SWB:ECJ
|
US |
|
PCBL Ltd
NSE:PCBL
|
IN |
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
|
E
|
eEducation Albert AB
STO:ALBERT
|
SE |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
CH |
|
E
|
Eurofins Scientific SE
DUS:ESF0
|
LU |
|
A
|
Aviva PLC
XBER:GU8
|
UK |
|
Schibsted ASA
F:XPG
|
NO |
|
Checkin.com Group AB
F:7I1
|
SE |
|
Finwise Bancorp
NASDAQ:FINW
|
US |
|
J
|
Juva Life Inc
CNSX:JUVA
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APLT's stock price target?
Not Available
APLT does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Applied Therapeutics Inc?
Projected CAGR
248%
248%
The compound annual growth rate for Revenue over the next 4 years is 248%.
